nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—HTR2B—cardial valve—systemic scleroderma	0.09	0.344	CbGeAlD
Apomorphine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0275	0.105	CbGeAlD
Apomorphine—HTR2A—pulmonary artery—systemic scleroderma	0.0195	0.0742	CbGeAlD
Apomorphine—HTR1B—artery—systemic scleroderma	0.015	0.0572	CbGeAlD
Apomorphine—HTR1D—artery—systemic scleroderma	0.0145	0.0554	CbGeAlD
Apomorphine—HTR1B—blood vessel—systemic scleroderma	0.0117	0.0446	CbGeAlD
Apomorphine—HTR1D—blood vessel—systemic scleroderma	0.0113	0.0432	CbGeAlD
Apomorphine—HTR2A—artery—systemic scleroderma	0.00721	0.0275	CbGeAlD
Apomorphine—HTR2A—endothelium—systemic scleroderma	0.00609	0.0232	CbGeAlD
Apomorphine—HTR1D—connective tissue—systemic scleroderma	0.0058	0.0221	CbGeAlD
Apomorphine—HTR2A—blood vessel—systemic scleroderma	0.00562	0.0214	CbGeAlD
Apomorphine—Urinary tract infection—Mometasone—systemic scleroderma	0.00507	0.00687	CcSEcCtD
Apomorphine—Injection site reaction—Mycophenolate mofetil—systemic scleroderma	0.00505	0.00685	CcSEcCtD
Apomorphine—Flushing—Pentoxifylline—systemic scleroderma	0.00504	0.00682	CcSEcCtD
Apomorphine—Angina pectoris—Captopril—systemic scleroderma	0.00501	0.00678	CcSEcCtD
Apomorphine—HTR2B—smooth muscle tissue—systemic scleroderma	0.00493	0.0188	CbGeAlD
Apomorphine—HTR2B—skin of body—systemic scleroderma	0.00487	0.0186	CbGeAlD
Apomorphine—Pain in extremity—Mycophenolic acid—systemic scleroderma	0.00467	0.00633	CcSEcCtD
Apomorphine—Ecchymosis—Mycophenolate mofetil—systemic scleroderma	0.00459	0.00623	CcSEcCtD
Apomorphine—Back pain—Pentoxifylline—systemic scleroderma	0.00457	0.00619	CcSEcCtD
Apomorphine—Psychotic disorder—Mycophenolic acid—systemic scleroderma	0.00457	0.00619	CcSEcCtD
Apomorphine—Dehydration—Mycophenolic acid—systemic scleroderma	0.00435	0.00589	CcSEcCtD
Apomorphine—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.00427	0.00579	CcSEcCtD
Apomorphine—Pain in extremity—Lisinopril—systemic scleroderma	0.00421	0.00571	CcSEcCtD
Apomorphine—Nasopharyngitis—Mycophenolic acid—systemic scleroderma	0.00418	0.00566	CcSEcCtD
Apomorphine—Disturbance in sexual arousal—Lisinopril—systemic scleroderma	0.00418	0.00566	CcSEcCtD
Apomorphine—Sweating increased—Leflunomide—systemic scleroderma	0.00413	0.00559	CcSEcCtD
Apomorphine—Angina pectoris—Leflunomide—systemic scleroderma	0.00413	0.00559	CcSEcCtD
Apomorphine—Hallucination—Captopril—systemic scleroderma	0.00409	0.00555	CcSEcCtD
Apomorphine—Cardiac failure congestive—Mycophenolate mofetil—systemic scleroderma	0.00407	0.00551	CcSEcCtD
Apomorphine—Chest pain—Pentoxifylline—systemic scleroderma	0.00402	0.00545	CcSEcCtD
Apomorphine—Pneumonia—Azathioprine—systemic scleroderma	0.00402	0.00545	CcSEcCtD
Apomorphine—Anxiety—Pentoxifylline—systemic scleroderma	0.00401	0.00543	CcSEcCtD
Apomorphine—Contusion—Prednisone—systemic scleroderma	0.00395	0.00535	CcSEcCtD
Apomorphine—Back pain—Mometasone—systemic scleroderma	0.00394	0.00534	CcSEcCtD
Apomorphine—Angina pectoris—Mycophenolic acid—systemic scleroderma	0.00394	0.00533	CcSEcCtD
Apomorphine—Dehydration—Lisinopril—systemic scleroderma	0.00392	0.00531	CcSEcCtD
Apomorphine—HTR2B—digestive system—systemic scleroderma	0.0039	0.0149	CbGeAlD
Apomorphine—Confusional state—Pentoxifylline—systemic scleroderma	0.00389	0.00527	CcSEcCtD
Apomorphine—Oedema—Pentoxifylline—systemic scleroderma	0.00386	0.00522	CcSEcCtD
Apomorphine—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.00385	0.00521	CcSEcCtD
Apomorphine—Flushing—Captopril—systemic scleroderma	0.00382	0.00517	CcSEcCtD
Apomorphine—Pneumonia—Leflunomide—systemic scleroderma	0.0038	0.00515	CcSEcCtD
Apomorphine—Shock—Pentoxifylline—systemic scleroderma	0.00379	0.00514	CcSEcCtD
Apomorphine—Nasopharyngitis—Lisinopril—systemic scleroderma	0.00376	0.0051	CcSEcCtD
Apomorphine—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00373	0.00505	CcSEcCtD
Apomorphine—HTR2B—tendon—systemic scleroderma	0.00371	0.0141	CbGeAlD
Apomorphine—Urinary tract infection—Leflunomide—systemic scleroderma	0.00367	0.00497	CcSEcCtD
Apomorphine—Pneumonia—Mycophenolic acid—systemic scleroderma	0.00362	0.00491	CcSEcCtD
Apomorphine—Hypotension—Pentoxifylline—systemic scleroderma	0.0036	0.00488	CcSEcCtD
Apomorphine—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.0036	0.00488	CcSEcCtD
Apomorphine—Angina pectoris—Lisinopril—systemic scleroderma	0.00354	0.0048	CcSEcCtD
Apomorphine—Sweating increased—Lisinopril—systemic scleroderma	0.00354	0.0048	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00351	0.00476	CcSEcCtD
Apomorphine—Urinary tract infection—Mycophenolic acid—systemic scleroderma	0.0035	0.00474	CcSEcCtD
Apomorphine—Insomnia—Pentoxifylline—systemic scleroderma	0.00349	0.00473	CcSEcCtD
Apomorphine—Chest pain—Mometasone—systemic scleroderma	0.00347	0.0047	CcSEcCtD
Apomorphine—Arthralgia—Mometasone—systemic scleroderma	0.00347	0.0047	CcSEcCtD
Apomorphine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00344	0.00466	CcSEcCtD
Apomorphine—Dehydration—Mycophenolate mofetil—systemic scleroderma	0.00343	0.00465	CcSEcCtD
Apomorphine—Somnolence—Pentoxifylline—systemic scleroderma	0.00343	0.00464	CcSEcCtD
Apomorphine—ADRA2A—connective tissue—systemic scleroderma	0.00339	0.0129	CbGeAlD
Apomorphine—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00337	0.00457	CcSEcCtD
Apomorphine—Constipation—Pentoxifylline—systemic scleroderma	0.0033	0.00447	CcSEcCtD
Apomorphine—Pneumonia—Lisinopril—systemic scleroderma	0.00326	0.00442	CcSEcCtD
Apomorphine—HTR2B—lung—systemic scleroderma	0.00325	0.0124	CbGeAlD
Apomorphine—Hallucination—Mycophenolic acid—systemic scleroderma	0.00322	0.00436	CcSEcCtD
Apomorphine—Syncope—Captopril—systemic scleroderma	0.00321	0.00435	CcSEcCtD
Apomorphine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00318	0.00431	CcSEcCtD
Apomorphine—Urinary tract infection—Lisinopril—systemic scleroderma	0.00315	0.00427	CcSEcCtD
Apomorphine—Loss of consciousness—Captopril—systemic scleroderma	0.00315	0.00426	CcSEcCtD
Apomorphine—Ecchymosis—Prednisone—systemic scleroderma	0.00311	0.00422	CcSEcCtD
Apomorphine—Angina pectoris—Mycophenolate mofetil—systemic scleroderma	0.00311	0.00421	CcSEcCtD
Apomorphine—Arthralgia—Captopril—systemic scleroderma	0.00305	0.00413	CcSEcCtD
Apomorphine—Chest pain—Captopril—systemic scleroderma	0.00305	0.00413	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00303	0.00411	CcSEcCtD
Apomorphine—Mental disorder—Leflunomide—systemic scleroderma	0.00297	0.00402	CcSEcCtD
Apomorphine—Dyspnoea—Mometasone—systemic scleroderma	0.00297	0.00402	CcSEcCtD
Apomorphine—Confusional state—Captopril—systemic scleroderma	0.00295	0.00399	CcSEcCtD
Apomorphine—ADRA2C—tendon—systemic scleroderma	0.00292	0.0111	CbGeAlD
Apomorphine—Hallucination—Lisinopril—systemic scleroderma	0.0029	0.00393	CcSEcCtD
Apomorphine—HTR2A—connective tissue—systemic scleroderma	0.00288	0.011	CbGeAlD
Apomorphine—Shock—Captopril—systemic scleroderma	0.00287	0.0039	CcSEcCtD
Apomorphine—Fatigue—Mometasone—systemic scleroderma	0.00287	0.00389	CcSEcCtD
Apomorphine—Pneumonia—Mycophenolate mofetil—systemic scleroderma	0.00286	0.00387	CcSEcCtD
Apomorphine—Back pain—Leflunomide—systemic scleroderma	0.00285	0.00387	CcSEcCtD
Apomorphine—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00283	0.00384	CcSEcCtD
Apomorphine—Asthenia—Pentoxifylline—systemic scleroderma	0.00277	0.00375	CcSEcCtD
Apomorphine—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.00276	0.00374	CcSEcCtD
Apomorphine—Cardiac failure congestive—Prednisone—systemic scleroderma	0.00276	0.00374	CcSEcCtD
Apomorphine—Hypotension—Captopril—systemic scleroderma	0.00273	0.0037	CcSEcCtD
Apomorphine—Pruritus—Pentoxifylline—systemic scleroderma	0.00273	0.0037	CcSEcCtD
Apomorphine—Back pain—Mycophenolic acid—systemic scleroderma	0.00272	0.00369	CcSEcCtD
Apomorphine—Flushing—Lisinopril—systemic scleroderma	0.0027	0.00366	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00266	0.00361	CcSEcCtD
Apomorphine—Arthralgia—Azathioprine—systemic scleroderma	0.00266	0.0036	CcSEcCtD
Apomorphine—Insomnia—Captopril—systemic scleroderma	0.00264	0.00358	CcSEcCtD
Apomorphine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00264	0.00357	CcSEcCtD
Apomorphine—HTR2A—smooth muscle tissue—systemic scleroderma	0.00263	0.0101	CbGeAlD
Apomorphine—DRD2—lung—systemic scleroderma	0.00263	0.0101	CbGeAlD
Apomorphine—Dyspnoea—Captopril—systemic scleroderma	0.00261	0.00353	CcSEcCtD
Apomorphine—Ecchymosis—Methotrexate—systemic scleroderma	0.0026	0.00353	CcSEcCtD
Apomorphine—Somnolence—Captopril—systemic scleroderma	0.0026	0.00352	CcSEcCtD
Apomorphine—ADRA2C—lung—systemic scleroderma	0.00256	0.00977	CbGeAlD
Apomorphine—Mental disorder—Lisinopril—systemic scleroderma	0.00255	0.00346	CcSEcCtD
Apomorphine—Dizziness—Pentoxifylline—systemic scleroderma	0.00255	0.00345	CcSEcCtD
Apomorphine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00254	0.00344	CcSEcCtD
Apomorphine—Syncope—Mycophenolic acid—systemic scleroderma	0.00252	0.00342	CcSEcCtD
Apomorphine—Fatigue—Captopril—systemic scleroderma	0.00252	0.00341	CcSEcCtD
Apomorphine—Arthralgia—Leflunomide—systemic scleroderma	0.00251	0.0034	CcSEcCtD
Apomorphine—Chest pain—Leflunomide—systemic scleroderma	0.00251	0.0034	CcSEcCtD
Apomorphine—Anxiety—Leflunomide—systemic scleroderma	0.0025	0.00339	CcSEcCtD
Apomorphine—Constipation—Captopril—systemic scleroderma	0.0025	0.00339	CcSEcCtD
Apomorphine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00247	0.00335	CcSEcCtD
Apomorphine—Back pain—Lisinopril—systemic scleroderma	0.00245	0.00332	CcSEcCtD
Apomorphine—Vomiting—Pentoxifylline—systemic scleroderma	0.00245	0.00332	CcSEcCtD
Apomorphine—Psychotic disorder—Prednisone—systemic scleroderma	0.00244	0.00331	CcSEcCtD
Apomorphine—Headache—Pentoxifylline—systemic scleroderma	0.00242	0.00327	CcSEcCtD
Apomorphine—Feeling abnormal—Captopril—systemic scleroderma	0.00241	0.00326	CcSEcCtD
Apomorphine—Arthralgia—Mycophenolic acid—systemic scleroderma	0.0024	0.00325	CcSEcCtD
Apomorphine—Chest pain—Mycophenolic acid—systemic scleroderma	0.0024	0.00325	CcSEcCtD
Apomorphine—Anxiety—Mycophenolic acid—systemic scleroderma	0.00239	0.00324	CcSEcCtD
Apomorphine—Asthenia—Mometasone—systemic scleroderma	0.00239	0.00323	CcSEcCtD
Apomorphine—Hypotension—Azathioprine—systemic scleroderma	0.00238	0.00323	CcSEcCtD
Apomorphine—Pruritus—Mometasone—systemic scleroderma	0.00235	0.00319	CcSEcCtD
Apomorphine—ADRA2A—tendon—systemic scleroderma	0.00233	0.00889	CbGeAlD
Apomorphine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00233	0.00315	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00232	0.00315	CcSEcCtD
Apomorphine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00232	0.00314	CcSEcCtD
Apomorphine—Oedema—Mycophenolic acid—systemic scleroderma	0.0023	0.00311	CcSEcCtD
Apomorphine—Nausea—Pentoxifylline—systemic scleroderma	0.00229	0.0031	CcSEcCtD
Apomorphine—Diarrhoea—Mometasone—systemic scleroderma	0.00228	0.00308	CcSEcCtD
Apomorphine—Syncope—Lisinopril—systemic scleroderma	0.00227	0.00308	CcSEcCtD
Apomorphine—Shock—Mycophenolic acid—systemic scleroderma	0.00226	0.00306	CcSEcCtD
Apomorphine—Hypotension—Leflunomide—systemic scleroderma	0.00225	0.00305	CcSEcCtD
Apomorphine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00224	0.00303	CcSEcCtD
Apomorphine—Loss of consciousness—Lisinopril—systemic scleroderma	0.00223	0.00302	CcSEcCtD
Apomorphine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00222	0.00301	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00219	0.00297	CcSEcCtD
Apomorphine—Insomnia—Leflunomide—systemic scleroderma	0.00218	0.00295	CcSEcCtD
Apomorphine—Arthralgia—Lisinopril—systemic scleroderma	0.00216	0.00293	CcSEcCtD
Apomorphine—Chest pain—Lisinopril—systemic scleroderma	0.00216	0.00293	CcSEcCtD
Apomorphine—Anxiety—Lisinopril—systemic scleroderma	0.00215	0.00291	CcSEcCtD
Apomorphine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00215	0.00291	CcSEcCtD
Apomorphine—Dyspnoea—Leflunomide—systemic scleroderma	0.00215	0.00291	CcSEcCtD
Apomorphine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00215	0.00291	CcSEcCtD
Apomorphine—Vomiting—Mometasone—systemic scleroderma	0.00212	0.00287	CcSEcCtD
Apomorphine—Sweating increased—Prednisone—systemic scleroderma	0.00211	0.00285	CcSEcCtD
Apomorphine—Feeling abnormal—Azathioprine—systemic scleroderma	0.0021	0.00285	CcSEcCtD
Apomorphine—Asthenia—Captopril—systemic scleroderma	0.0021	0.00284	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00209	0.00284	CcSEcCtD
Apomorphine—Confusional state—Lisinopril—systemic scleroderma	0.00209	0.00283	CcSEcCtD
Apomorphine—Headache—Mometasone—systemic scleroderma	0.00208	0.00282	CcSEcCtD
Apomorphine—HTR2A—digestive system—systemic scleroderma	0.00208	0.00794	CbGeAlD
Apomorphine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00208	0.00282	CcSEcCtD
Apomorphine—Fatigue—Leflunomide—systemic scleroderma	0.00208	0.00281	CcSEcCtD
Apomorphine—Oedema—Lisinopril—systemic scleroderma	0.00207	0.0028	CcSEcCtD
Apomorphine—Pruritus—Captopril—systemic scleroderma	0.00207	0.0028	CcSEcCtD
Apomorphine—Constipation—Leflunomide—systemic scleroderma	0.00206	0.00279	CcSEcCtD
Apomorphine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00205	0.00278	CcSEcCtD
Apomorphine—ADRA2A—lung—systemic scleroderma	0.00204	0.0078	CbGeAlD
Apomorphine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00204	0.00277	CcSEcCtD
Apomorphine—Shock—Lisinopril—systemic scleroderma	0.00204	0.00276	CcSEcCtD
Apomorphine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.002	0.00271	CcSEcCtD
Apomorphine—Diarrhoea—Captopril—systemic scleroderma	0.002	0.00271	CcSEcCtD
Apomorphine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00199	0.0027	CcSEcCtD
Apomorphine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00198	0.00269	CcSEcCtD
Apomorphine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00198	0.00268	CcSEcCtD
Apomorphine—HTR2A—tendon—systemic scleroderma	0.00198	0.00756	CbGeAlD
Apomorphine—Nausea—Mometasone—systemic scleroderma	0.00198	0.00268	CcSEcCtD
Apomorphine—Constipation—Mycophenolic acid—systemic scleroderma	0.00196	0.00266	CcSEcCtD
Apomorphine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00195	0.00265	CcSEcCtD
Apomorphine—Hypotension—Lisinopril—systemic scleroderma	0.00193	0.00262	CcSEcCtD
Apomorphine—Dizziness—Captopril—systemic scleroderma	0.00193	0.00262	CcSEcCtD
Apomorphine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00189	0.00257	CcSEcCtD
Apomorphine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00189	0.00256	CcSEcCtD
Apomorphine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00189	0.00256	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00189	0.00255	CcSEcCtD
Apomorphine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00255	CcSEcCtD
Apomorphine—Insomnia—Lisinopril—systemic scleroderma	0.00187	0.00254	CcSEcCtD
Apomorphine—Vomiting—Captopril—systemic scleroderma	0.00186	0.00252	CcSEcCtD
Apomorphine—Dyspnoea—Lisinopril—systemic scleroderma	0.00184	0.0025	CcSEcCtD
Apomorphine—Somnolence—Lisinopril—systemic scleroderma	0.00184	0.00249	CcSEcCtD
Apomorphine—Headache—Captopril—systemic scleroderma	0.00183	0.00248	CcSEcCtD
Apomorphine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00183	0.00248	CcSEcCtD
Apomorphine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00181	0.00246	CcSEcCtD
Apomorphine—Fatigue—Lisinopril—systemic scleroderma	0.00178	0.00242	CcSEcCtD
Apomorphine—Shock—Mycophenolate mofetil—systemic scleroderma	0.00178	0.00242	CcSEcCtD
Apomorphine—Constipation—Lisinopril—systemic scleroderma	0.00177	0.0024	CcSEcCtD
Apomorphine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00238	CcSEcCtD
Apomorphine—Diarrhoea—Azathioprine—systemic scleroderma	0.00174	0.00236	CcSEcCtD
Apomorphine—HTR2A—lung—systemic scleroderma	0.00174	0.00663	CbGeAlD
Apomorphine—Nausea—Captopril—systemic scleroderma	0.00174	0.00235	CcSEcCtD
Apomorphine—Asthenia—Leflunomide—systemic scleroderma	0.00173	0.00234	CcSEcCtD
Apomorphine—Hallucination—Prednisone—systemic scleroderma	0.00172	0.00233	CcSEcCtD
Apomorphine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00171	0.00231	CcSEcCtD
Apomorphine—Pruritus—Leflunomide—systemic scleroderma	0.0017	0.00231	CcSEcCtD
Apomorphine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00169	0.0023	CcSEcCtD
Apomorphine—Dizziness—Azathioprine—systemic scleroderma	0.00169	0.00229	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00165	0.00224	CcSEcCtD
Apomorphine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00165	0.00223	CcSEcCtD
Apomorphine—Diarrhoea—Leflunomide—systemic scleroderma	0.00165	0.00223	CcSEcCtD
Apomorphine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00164	0.00222	CcSEcCtD
Apomorphine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00163	0.0022	CcSEcCtD
Apomorphine—Vomiting—Azathioprine—systemic scleroderma	0.00162	0.0022	CcSEcCtD
Apomorphine—Pneumonia—Methotrexate—systemic scleroderma	0.00162	0.00219	CcSEcCtD
Apomorphine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00219	CcSEcCtD
Apomorphine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00218	CcSEcCtD
Apomorphine—Drowsiness—Methotrexate—systemic scleroderma	0.00161	0.00218	CcSEcCtD
Apomorphine—Flushing—Prednisone—systemic scleroderma	0.00161	0.00218	CcSEcCtD
Apomorphine—Headache—Azathioprine—systemic scleroderma	0.0016	0.00216	CcSEcCtD
Apomorphine—Dizziness—Leflunomide—systemic scleroderma	0.00159	0.00216	CcSEcCtD
Apomorphine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00157	0.00213	CcSEcCtD
Apomorphine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00155	0.0021	CcSEcCtD
Apomorphine—Vomiting—Leflunomide—systemic scleroderma	0.00153	0.00207	CcSEcCtD
Apomorphine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00152	0.00206	CcSEcCtD
Apomorphine—Mental disorder—Prednisone—systemic scleroderma	0.00152	0.00205	CcSEcCtD
Apomorphine—Nausea—Azathioprine—systemic scleroderma	0.00151	0.00205	CcSEcCtD
Apomorphine—Headache—Leflunomide—systemic scleroderma	0.00151	0.00204	CcSEcCtD
Apomorphine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00202	CcSEcCtD
Apomorphine—Asthenia—Lisinopril—systemic scleroderma	0.00148	0.00201	CcSEcCtD
Apomorphine—Pruritus—Lisinopril—systemic scleroderma	0.00146	0.00198	CcSEcCtD
Apomorphine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00146	0.00198	CcSEcCtD
Apomorphine—Headache—Mycophenolic acid—systemic scleroderma	0.00144	0.00195	CcSEcCtD
Apomorphine—Nausea—Leflunomide—systemic scleroderma	0.00143	0.00194	CcSEcCtD
Apomorphine—Diarrhoea—Lisinopril—systemic scleroderma	0.00142	0.00192	CcSEcCtD
Apomorphine—Dizziness—Lisinopril—systemic scleroderma	0.00137	0.00185	CcSEcCtD
Apomorphine—Nausea—Mycophenolic acid—systemic scleroderma	0.00136	0.00185	CcSEcCtD
Apomorphine—Syncope—Prednisone—systemic scleroderma	0.00135	0.00183	CcSEcCtD
Apomorphine—Loss of consciousness—Prednisone—systemic scleroderma	0.00132	0.00179	CcSEcCtD
Apomorphine—Vomiting—Lisinopril—systemic scleroderma	0.00132	0.00178	CcSEcCtD
Apomorphine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.0013	0.00176	CcSEcCtD
Apomorphine—Headache—Lisinopril—systemic scleroderma	0.0013	0.00176	CcSEcCtD
Apomorphine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00174	CcSEcCtD
Apomorphine—Arthralgia—Prednisone—systemic scleroderma	0.00128	0.00174	CcSEcCtD
Apomorphine—Anxiety—Prednisone—systemic scleroderma	0.00128	0.00173	CcSEcCtD
Apomorphine—Mental disorder—Methotrexate—systemic scleroderma	0.00127	0.00172	CcSEcCtD
Apomorphine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00168	CcSEcCtD
Apomorphine—Nausea—Lisinopril—systemic scleroderma	0.00123	0.00167	CcSEcCtD
Apomorphine—Oedema—Prednisone—systemic scleroderma	0.00123	0.00167	CcSEcCtD
Apomorphine—Back pain—Methotrexate—systemic scleroderma	0.00122	0.00165	CcSEcCtD
Apomorphine—Shock—Prednisone—systemic scleroderma	0.00121	0.00164	CcSEcCtD
Apomorphine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.0012	0.00162	CcSEcCtD
Apomorphine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00119	0.00161	CcSEcCtD
Apomorphine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00156	CcSEcCtD
Apomorphine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00154	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00112	0.00152	CcSEcCtD
Apomorphine—Insomnia—Prednisone—systemic scleroderma	0.00111	0.00151	CcSEcCtD
Apomorphine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00146	CcSEcCtD
Apomorphine—Chest pain—Methotrexate—systemic scleroderma	0.00107	0.00145	CcSEcCtD
Apomorphine—Arthralgia—Methotrexate—systemic scleroderma	0.00107	0.00145	CcSEcCtD
Apomorphine—Fatigue—Prednisone—systemic scleroderma	0.00106	0.00144	CcSEcCtD
Apomorphine—Constipation—Prednisone—systemic scleroderma	0.00105	0.00142	CcSEcCtD
Apomorphine—Confusional state—Methotrexate—systemic scleroderma	0.00104	0.0014	CcSEcCtD
Apomorphine—Feeling abnormal—Prednisone—systemic scleroderma	0.00101	0.00137	CcSEcCtD
Apomorphine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000993	0.00135	CcSEcCtD
Apomorphine—Hypotension—Methotrexate—systemic scleroderma	0.00096	0.0013	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000936	0.00127	CcSEcCtD
Apomorphine—Insomnia—Methotrexate—systemic scleroderma	0.000929	0.00126	CcSEcCtD
Apomorphine—Dyspnoea—Methotrexate—systemic scleroderma	0.000916	0.00124	CcSEcCtD
Apomorphine—Somnolence—Methotrexate—systemic scleroderma	0.000913	0.00124	CcSEcCtD
Apomorphine—Fatigue—Methotrexate—systemic scleroderma	0.000886	0.0012	CcSEcCtD
Apomorphine—Asthenia—Prednisone—systemic scleroderma	0.000882	0.00119	CcSEcCtD
Apomorphine—Pruritus—Prednisone—systemic scleroderma	0.00087	0.00118	CcSEcCtD
Apomorphine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000846	0.00115	CcSEcCtD
Apomorphine—Diarrhoea—Prednisone—systemic scleroderma	0.000841	0.00114	CcSEcCtD
Apomorphine—Dizziness—Prednisone—systemic scleroderma	0.000813	0.0011	CcSEcCtD
Apomorphine—Vomiting—Prednisone—systemic scleroderma	0.000781	0.00106	CcSEcCtD
Apomorphine—Headache—Prednisone—systemic scleroderma	0.00077	0.00104	CcSEcCtD
Apomorphine—Asthenia—Methotrexate—systemic scleroderma	0.000737	0.000999	CcSEcCtD
Apomorphine—Nausea—Prednisone—systemic scleroderma	0.00073	0.000989	CcSEcCtD
Apomorphine—Pruritus—Methotrexate—systemic scleroderma	0.000727	0.000985	CcSEcCtD
Apomorphine—Diarrhoea—Methotrexate—systemic scleroderma	0.000703	0.000952	CcSEcCtD
Apomorphine—Dizziness—Methotrexate—systemic scleroderma	0.000679	0.00092	CcSEcCtD
Apomorphine—Vomiting—Methotrexate—systemic scleroderma	0.000653	0.000885	CcSEcCtD
Apomorphine—Headache—Methotrexate—systemic scleroderma	0.000643	0.000872	CcSEcCtD
Apomorphine—Nausea—Methotrexate—systemic scleroderma	0.00061	0.000827	CcSEcCtD
